New dosing strategy aims to keep myeloma patients out of the hospital
NCT ID NCT06421675
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 31 times
Summary
This study tests a new way of giving the drug elranatamab to people with multiple myeloma that has come back or stopped responding to other treatments. The goal is to see if giving the drug in an outpatient setting and on a less frequent schedule can reduce hospital stays and serious infections. About 40 participants will receive elranatamab alone, and researchers will track how safe and tolerable the new dosing plan is.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Juravinski Cancer Center
RECRUITINGHamilton, Ontario, L8V 1C3, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Kingston General Hospital
RECRUITINGKingston, Ontario, K7L 2V7, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
London Health Science Centre - Victoria Hospital
NOT_YET_RECRUITINGLondon, Ontario, N6A 5W9, Canada
-
Ottawa Hospital
RECRUITINGOttawa, Ontario, K1H 8L6, Canada
Contact Phone: •••-•••-••••
-
Vancouver Cancer Center
RECRUITINGVancouver, British Columbia, V5Z 1L3, Canada
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.